Menu

Be sure to take a good look at the pharmacy’s customer support and medicine service availability on Essenceapotek. You intend to make certain you contact MPs in many ways and that you can communicate all night to get to get assist if anything fails together with your medicine.

Vergleich von allogenen und autologen Blöcken zur Kieferkammaugmentation – eine retrospektive radiografische Untersuchung über 12 Monate   Kloss  et al, Clin Oral Implants Res. 2018 Oct 10. doi: 10.1111/clr.13380. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30303581     Studienziel: Retrospektive Studie zur Untersuchung der dreidimensionalen Veränderungen von autogenen und allogenen Blöcken nach Augmentation von Einzelzahndefekten Methode: Die alveolare Knochenbreite an spezifischen Implantatpositionen wurde mittels DVT-Aufnahmen (sagittal und im Querschnitt) vor Augmentation und an drei nachfolgenden Zeitpunkten untersucht. Bei 21 Patienten wurden autologe Knochenblöcke (Entnahme aus der retromolaren Region), bei weiteren 21 Patienten gefriergetrocknete, spongiöse allogene Knochenblöcke verwendet. Ergebnisse: Die vertikalen und horizontalen Abmessungen unterschieden sich zu keinem Zeitpunkt signifikant zwischen autogenen und allogenen Knochenblöcken. Darüber hinaus gab es keine statistisch signifikanten Unterschiede in den Remodelling-Raten zwischen autogenen (mittlere Schrumpfrate nach 12 Monaten: 12,5 ± 7,8 %) und allogenen Onlay-Grafts (mittlere Schrumpfrate nach 12 Monaten: 14,4 ± 9,8 %). Schlussfolgerung: Gefriergetrocknete spongiöse allogene Knochenblöcke zeigten äquivalente volumetrische Schrumpfungsraten wie autogene Knochenblöcke, wenn sie zur Behandlung umschriebener...

With the introduction of permamem®, botiss expands its regeneration system by offering an exceptionally thin, non-resorbable, biologically inert and biocompatible membrane made of 100% high-density polytetrafluoroethylene (PTFE). permamem® maintains its structural integrity during implantation and over time. Due to its small pore size the membrane acts as an efficient barrier against bacterial and cellular penetration, and may therefore be left in place for open healing in certain clinical indications. permamem® can easily be removed after the desired healing time with a pair of tweezers. After removal, the primary healing process and the reepithelialization of the regenerating soft tissue will be completed within one month. permamem® fulfills the requirements of biocompatibility according to EN ISO 10993-1 and EN ISO 7405. The biocompatibility of the membrane has been proven by in vivo preclinical data [1]. > MORE ABOUT PERMAMEM® [1] Barbeck M. et al. unpublished...

Last year more than 20 scientific articles were published on botiss' hard and soft tissue products. Among the most recent ones, have a look at the: - NEW STUDY on cerabone® - NEUE STUDIE zu maxresorb® Take a look at our compilation of published scientific articles on botiss-dental.com and botiss.com.    ...

[vc_row row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css_animation=""][vc_column][vc_column_text] Dear Customers, During the Christmas holidays (24.12.2016 to 01.01.2017) our office is only partly occupied. We will process your requests on January 2nd. Thank you very much for your understanding. Your botiss biomaterials Team [/vc_column_text][/vc_column][/vc_row]...

On November the 25th, the 2nd mucoderm® expert meeting has taken place in Hamburg, Germany. The aim of the meeting was to review the currently available clinical/scientific data, in order to set up further guidelines for the use of the porcine matrix in established indications and explore new fields of indications/limitations of mucoderm®. To this end, botiss and Straumann invited seven experienced clinicians with different specializations. Prof. Dr. Adrian Kasaj (University of Mainz, Germany), Dr. Raluca Cosgarea (University Cluij-Napocca, Romania and Marburg, Germany), and Dr. Attila Horváth (University of Budapest, Hungary) presented their results obtained with mucoderm® in combination with the modified coronally advanced tunnel or the Zucchelli technique for the treatment of gingival recessions, showing predictable results for Miller class I and II recessions. Dr. Dominiki Chatzopoulou (University of London, UK) pointed out the potential benefits of combining mucoderm® with Emdogain®, particularly for compromised patients and smokers. Dr. Alessandro Rossi (University...

Parallel to the DGI annual meeting, the second expert meeting on mucoderm® will take place in Hamburg on 25.11. The group of international renowned clinicians will discuss recent study results, the current state of scientific evidence as well as surgical procedures and protocols for the following indications: recession coverage, augmentation of the attached gingiva and soft tissue thickening. We are looking forward to the stimulating exchange of scientific/clinical knowledge and the resulting outcome.  ...